Goals achieved for ASA at Arab Health (30 January - 2 February 2023, Dubai), one of the most important international industry fairs.
Not only did the company strengthen relations with current partners and intercept valuable new ones, but it also successfully promoted its therapeutic solutions on new markets of interest. The experience was especially positive for the staff involved, mainly thanks to having an own exhibition space for the first time in the sector reserved for Capital Equipment.
“The decision taken to set up in this pavilion was a winning one. We could be reached easily and were in an area with a large influx: they were four particularly intense days.” Alberto Fera, ASA Area Manager comments.
The possibility of interacting first hand with the ASA devices most sold in the Arab world also contributed to stimulate participants’ curiosity towards the uses and benefits of MLS® Laser Therapy and Hilterapia®.
“This factor also contributed to making a difference, as it is a tangible support to the activities of our partners’ sales teams. Indeed, thanks to their collaboration, many potential clients visited us and were given a presentation directly by our staff. An important added value, the result of the relationships built up with our partners”, Fera concludes.
In light of the many meetings held and of the consequent development opportunities that derived, Arab Health was confirmed a pivotal event for ASA’s worldwide promotional and sales activity, something that was confirmed by the nationalities of the visitors, who attended from all the continents.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.